Rubrik: GxP
(Treffer aus pharmind, Nr. 08, Seite 608 (2026))
Gjorgjevska M
Annex 1 in Non-Sterile Manufacturing / Navigating the Challenges of Implementing – Part 1*The views and interpretations shared in this paper are based on the personal professional experience and understanding of the author. They do not represent, reflect, or imply the official positions, policies, or practices of any current or past employer, partner, or affiliated organization. · Gjorgjevska M · Eli Lilly
Annex 1 Non-sterile Manufacture CCS QRM Microbiological Quality The 2022 revision of EudraLex Volume 4, Annex 1, represents one of the most significant updates to the EU GMP framework for sterile medicinal products in recent years. It was published on 22 Aug. 2022 and took effect on 25 Aug. 2023, with point 8.123 applying from 25 Aug. 2024. The revised annex places greater emphasis on contamination control, quality risk management (QRM), facility and process design, monitoring strategy, personnel practices, and lifecycle oversight. Its central objective remains the prevention of microbial, particulate, and endotoxin/pyrogen contamination in sterile medicinal products [ 1 ]. Although Annex 1 is written for ...